New safety data for the most commonly used drug to treat Chagas disease

(Barcelona Institute for Global Health (ISGlobal)) The frequency of adverse reactions to benznidazole is high when treating chronic Chagas patients, although they were mostly mild effects, according to a study led by ISGlobal, in collaboration with the Hospital Clinic of Barcelona. The results point to the need of finding drug combinations or dosages in order to maintain efficacy but decrease its toxicity.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news